CoChat

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children*

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: To evaluate the efficacy of several drug delivery patterns of methylphenidate and to determine whether acute tolerance develops to this widely used stimulant medication in the treatment of children with attention deficit hyperactivity disorder. METHODS: Double-blind trials were conducted in a laboratory school setting in which multiple measures of efficacy were obtained frequently in the morning and afternoon across the school day. In study I, relative efficacy was determined for three dosing patterns of methylphenidate: a standard twice-daily profile, a flat profile, and an ascending profile. In study II, tolerance was assessed by comparison of three-times-a-day regimens in which the time of the middle dose varied. RESULTS: In study I, the efficacy of the ascending treatment increased across the day, and in the afternoon it was equal to the efficacy of the twice-daily treatment, indicating that an initial bolus was not required for efficacy. The efficacy of the flat treatment declined across the day, and in the afternoon it was significantly less than in the twice-daily treatment, suggesting that tolerance may be developing. In study II, acute improvements in efficacy were reduced to the second of two closely spaced but not to two widely spaced bolus doses, suggesting that shortly after exposure to high concentrations, efficacy is reduced to given concentrations of methylphenidate. In a concentration-effect model, a tolerance term was needed to account for counterclockwise hysteresis. CONCLUSIONS: Acute tolerance to methylphenidate appears to exist. This should be considered in the design of an optimal dosing regimen for the treatment of children with attention deficit hyperactivity disorder.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0009-9236(99)70038-x

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 4

  1. Swanson J. M., 1986, Clin Neuropharmacol, 9, 523
  2. Wigal S. B., 1998, Psychopharmacol Bull, 34, 47
  3. Swanson J., 1998, Psychopharmacol Bull, 34, 55
  4. Porchet H. C., 1988, J Pharmacol Exp Ther, 244, 231

Cited by

See all 216

Metadata

Authors
Swanson, J., Gupta, S., Guinta, D., Flynn, D., Agler, D., Lerner, M., Williams, L., Shoulson, I., & Wigal, S.
Affiliations
University of California, Irvine (US)
Corresponding author
Swanson, James
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
1999-09
Volume
66
Issue
3
Pages
295-305
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2068924820
Cited by
216
References
35
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 3 · 2020: 8 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 8 · 2013: 7 · 2012: 7
FWCI
7.15
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
methylphenidate, acute tolerance, attention deficit hyperactivity disorder, children, dosing regimen, ascending dose, twice-daily dosing, hysteresis, stimulant medication
MeSH terms
Central Nervous System Stimulants, Analysis of Variance, Attention Deficit Disorder with Hyperactivity, Child, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Methylphenidate, Treatment Outcome, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children*. https://app.cochat.ai/papers/10.1016/s0009-9236(99)70038-x
The paper
Swanson, J., Gupta, S., Guinta, D., Flynn, D., Agler, D., Lerner, M., Williams, L., Shoulson, I., & Wigal, S. (1999). Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children*. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/s0009-9236(99)70038-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.